Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss-Reference-Cited by-同舟云学术

Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Published:2015-02-09 Issue:3 Volume:47 Page:263-266
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Xu Heng,Robinson Giles W,Huang Jie,Lim Joshua Yew-Suang,Zhang Hui,Bass Johnnie K,Broniscer Alberto,Chintagumpala Murali,Bartels Ute,Gururangan Sri,Hassall Tim,Fisher Michael,Cohn Richard,Yamashita Tetsuji,Teitz Tal,Zuo Jian,Onar-Thomas Arzu,Gajjar Amar,Stewart Clinton F,Yang Jun J

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.3217.pdf

Reference36 articles.

1. Cheung, N.V. & Heller, G. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J. Clin. Oncol. 9, 1050–1058 (1991).

2. Perilongo, G. et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N. Engl. J. Med. 361, 1662–1670 (2009).

3. Williams, S.D. et al. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N. Engl. J. Med. 316, 1435–1440 (1987).

4. Brock, P.R. et al. Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale. J. Clin. Oncol. 30, 2408–2417 (2012).

5. Langer, T., am Zehnhoff-Dinnesen, A., Radtke, S., Meitert, J. & Zolk, O. Understanding platinum-induced ototoxicity. Trends Pharmacol. Sci. 34, 458–469 (2013).

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy;Cancer Medicine;2024-08

2. ERK1/2 Inhibition via the Oral Administration of Tizaterkib Alleviates Noise-Induced Hearing Loss While Tempering down the Immune Response;International Journal of Molecular Sciences;2024-06-07

3. Combined genetic polymorphisms of the GSTT1 and NRF2 genes increase susceptibility to cisplatin-induced ototoxicity: A preliminary study;Hearing Research;2024-04

4. KSR1 knockout mouse model demonstrates MAPK pathway's key role in cisplatin- and noise-induced hearing loss;The Journal of Neuroscience;2024-03-28

5. The Relationship Between Pharmacogenomics and Pharmacokinetics and Its Impact on Drug Choice and Dosing Regimens in Pediatrics;ADME Processes in Pharmaceutical Sciences;2024